|
|
|
|
|
|
|
19.05.26 - 08:27
|
RefluxStop® gains momentum at DDW 2026 (PR Newswire)
|
|
|
VADUZ, Liechtenstein, May 19, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with 1 billion sufferers,......
|
|
|
|
|
|
|
|
|
18.05.26 - 15:36
|
Hansa Biopharma participating at LSX Nordic Congress (Cision)
|
|
|
Lund, Sweden, 18 May. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that Renée Aguiar-Lucander, CEO, Hansa Biopharma, be participating in a panel discussion titled “Scaling Success: Key Drivers for Growing Nordic Biotechs” at the LSX Nordic Congress, in Copenhagen, at 13:10 CEST on Tuesday 19 , 2026.
If you are interested in meeting with Hansa's management, please contact Hansa Biopharma at ir@hansabiopharma.com.
Event: Panel Discussion at LSX Nordic Congress
Title: Scaling Success: Key Drivers for Growing Nordic Biotechs
Date, Time, and Place: Tuesday 19...
|
|
|
18.05.26 - 15:18
|
Hamlet Biopharma Secures New Patents and Allowances, Going from Strength to Strength in Innovation and Technology (Cision)
|
|
|
[image]Hamlet Biopharma, a company innovating the treatment of cancer and infections, today announced the successful granting of new patents in Japan and India and a further patent allowance in Japan. The continued strengthening of Hamlet BioPharma's intellectual property portfolio reaffirms its position at the forefront of technological innovation.
The new patents and allowances cover breakthroughs in the HAMLET family of drug candidates, which effectively kill cancer cells and growing tumor tissue with high precision, as well as the company's technology relating to the treatment of...
|
|
|
18.05.26 - 14:24
|
Cabonline has signed school transport agreement with the City of Stockholm (Cision)
|
|
|
Cabonline has signed an agreement with the City of Stockholm for school transport services. Parts of the agreement have already entered into force, while additional contract areas will commence on 3 October 2026.
– This is an important assignment with high requirements for quality, planning and reliability. We are pleased with the continued trust from the City of Stockholm and look forward to continuing to deliver safe and accessible journeys across the city, says Erik Moberg, Head of B2P Cabonline, Cabonline Group.
Three out of five contract areas were awarded following a public...
|
|
|
|
|
18.05.26 - 12:01
|
Episurf Medical has completed the acquisition of the property portfolio from Mofast AB (Cision)
|
|
|
Episurf Medical AB (publ) (Nasdaq: EPIS B) today completed the acquisition of the property portfolio of 36 social infrastructure properties from Mofast AB (publ), with an agreed property value of approximately SEK 697 mn.
All conditions to closing have been satisfied, including approval from the senior lender and a decision from the Swedish Inspectorate of Strategic Products (ISP). The acquisition is financed by a major Nordic bank.
The B shares constituting part of the consideration to the seller will be issued following Episurf's annual general meeting on 25 May 2026, and before the end...
|
|
|
|
|
18.05.26 - 09:18
|
NOTICE OF ANNUAL GENERAL MEETING 2026 IN SPERMOSENS AB (publ) (Cision)
|
|
|
The shareholders of Spermosens AB (publ), reg. no. 559179-0380, are hereby invited to attend the Annual General Meeting on Thursday, 18 June 2026 at 10:00 a.m. at Medicon Village (The Spark), Scheeletorget 1, Lund, Sweden.
Right to participate and notice of participation
Shareholders wishing to participate in the Annual General Meeting must:
· be registered as shareholders in the share register maintained by Euroclear Sweden AB on Wednesday, 10 June 2026; and
· notify the company of their intention to participate no later than Friday, 12 June 2026, in writing to...
|
|
|
18.05.26 - 09:12
|
KALLELSE TILL ÅRSSTÄMMA 2026 I SPERMOSENS AB (publ) (Cision)
|
|
|
Aktieägarna i Spermosens AB, org. nr. 559179-0380, kallas härmed till årsstämma torsdagen den 18 juni 2026 kl. 10.00 på Medicon Village (The Spark), Scheeletorget 1, i Lund.
Rätt att delta och anmälan
Aktieägare som önskar delta i bolagsstämman ska
· vara upptagen som aktieägare i den av Euroclear Sweden AB förda aktieboken onsdagen den 10 juni 2026, och
· anmäla sig till bolaget senast fredagen den 12 juni 2026, skriftligen till Spermosens AB, Medicon Village, Scheeletorget 1, 223 81 Lund (märk brevet ”Årsstämma 2026”) eller per e-post till adressen info@spermosens.com....
|
|
|
|
|
|
|
|
|
|
|
|
|
15.05.26 - 08:36
|
Eisai projects Leqembi® revenue to total JPY 143.5 billion for fiscal year 2026 (April 2026 – March 2027) (Cision)
|
|
|
Stockholm, Sweden, May 15, 2026 – BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that Leqembi sales are expected to total JPY 143.5 billion (approximately SEK 8.4 billion) for their fiscal year (FY) 2026 (April 2026 through March 2027), corresponding to a 63 percent growth compared to the previous year. This would generate approximately SEK 880 M in royalty to BioArctic during the same period.
Leqembi is the result of a long-standing collaboration between BioArctic and Eisai, and the antibody was originally developed by BioArctic based on the work of Professor...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
